Long COVID Trial, Recruiting NCT06528171 Sponsor: Centre Hospitalier Universitaire de Nice Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT06528171
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people with Long COVID symptoms (CL+ group):

  • People whose condition matches the World Health Organization's agreed definition of Long COVID (confirm with trial site)

For people without ongoing COVID symptoms (Control/CL- group):

  • People who had COVID-19 (mild, moderate, or severe) at least 3 months before joining the trial
  • People who have no lasting symptoms beyond 3 months after their first COVID illness, or only very mild symptoms that do not affect daily life

Who may not be able to join:

For people with Long COVID symptoms (CL+ group):

  • People who had a diagnosis of chronic fatigue syndrome either before or after their COVID infection
  • People with a history of a serious, ongoing psychiatric condition
  • People whose original COVID illness was so severe that it required admission to an intensive care unit and mechanical ventilation (breathing machine)
  • People who are not affiliated with the French social security system

For people without ongoing COVID symptoms (Control/CL- group):

  • People with a history of a serious, ongoing psychiatric condition
  • People whose original COVID illness was so severe that it required admission to an intensive care unit and mechanical ventilation (breathing machine)
  • People who are not affiliated with the French social security system
  • People who are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 04 92 03 55 15

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 December 2024
Est. completion
1 June 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Predictive model of Covid-long

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov